Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenhalgh

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancerN Fleeman, A Bagust, C McLeod, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary interventionJ Greenhalgh, A Bagust, A Boland, et al.
The European Journal of Neuroscience|December 22, 2004
Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiationR J Lang, J M Haynes, J Kelly, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancerJ Greenhalgh, C McLeod, A Bagust, et al.
Endocrinology|January 18, 2006
Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic miceCarmen Z Michaylira, Nicole M Ramocki, James G Simmons, et al.
Health Technology Assessment (Winchester, England)|July 27, 2013
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Health Technology Assessment (Winchester, England)|December 11, 2008
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluationC McLeod, N Fleeman, J Kirkham, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b)Christopher J Greenhalgh, Patrick Bertolino, Sylvia L Asa, et al.
Analytical Chemistry|June 18, 2020
Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated TumorsCalum J Greenhalgh, Ellie Karekla, Gareth J Miles, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Health Technology Assessment (Winchester, England)|October 7, 2009
Rituximab for the treatment of rheumatoid arthritisA Bagust, A Boland, J Hockenhull, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancerN Fleeman, A Bagust, C McLeod, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary interventionJ Greenhalgh, A Bagust, A Boland, et al.
The European Journal of Neuroscience|December 22, 2004
Electrical and neurotransmitter activity of mature neurons derived from mouse embryonic stem cells by Sox-1 lineage selection and directed differentiationR J Lang, J M Haynes, J Kelly, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancerJ Greenhalgh, C McLeod, A Bagust, et al.
Endocrinology|January 18, 2006
Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic miceCarmen Z Michaylira, Nicole M Ramocki, James G Simmons, et al.
Health Technology Assessment (Winchester, England)|July 27, 2013
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Health Technology Assessment (Winchester, England)|December 11, 2008
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluationC McLeod, N Fleeman, J Kirkham, et al.
Molecular Endocrinology (Baltimore, Md.)|June 1, 2002
Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b)Christopher J Greenhalgh, Patrick Bertolino, Sylvia L Asa, et al.
Analytical Chemistry|June 18, 2020
Exploration of Matrix Effects in Laser Ablation Inductively Coupled Plasma Mass Spectrometry Imaging of Cisplatin-Treated TumorsCalum J Greenhalgh, Ellie Karekla, Gareth J Miles, et al.
Pageof 6